Surrozen (SRZN) News
NASDAQ: SRZNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SRZN news summary
We found 5 recent headlines mentioning Surrozen (SRZN): 1 in the past week and 4 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. SRZN is making an outsized move today, down 7.21% at $28.46, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Surrozen, Inc. Enters Underwriting Agreement for Common Stock Offering of 1,894,540 Shares", was published by Nasdaq on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Surrozen headlines
- Surrozen, Inc. Enters Underwriting Agreement for Common Stock Offering of 1,894,540 SharesOn November 13, 2026, Surrozen, Inc. entered into an underwriting agreement with Morgan Stanley & Co. LLC, Guggenheim Securities, LLC and Cantor Fitzgerald & Co. relating to the issuance and sale of…Nasdaq
- Surrozen Announces Pricing of $60 Million Underwritten Offering of Common StockSurrozen Announces Pricing of $60 Million Underwritten Offering of Common StockGlobeNewswire
- Surrozen GAAP EPS of -$11.02 misses by $9.92Seeking Alpha
- Surrozen to Present at Upcoming Healthcare Investor ConferenceSurrozen to Present at Upcoming Healthcare Investor ConferenceGlobeNewswire
- Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 MillionSurrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 MillionGlobeNewswire